Formulating Horizon Europe Budgets for Clinical Medicine & Trials

1. Financial Alignment & Eligibility Standards

Securing research funding from Horizon Europe framework programme requires meticulous adherence to both financial eligibility standards and administrative regulations. For projects in the domain of Clinical Medicine & Trials, budgets must be constructed using realistic cost projections that are directly tied to the scientific methodology. Under-budgeting may jeopardise project execution, while over-budgeting or including ineligible costs often leads to immediate rejection during administrative screening.

For wet-lab research in Clinical Medicine & Trials, budget formulations must prioritize chemical reagents, specialized assay consumables, and pay-per-use core facility fees. Investigators should avoid pooling general office supplies with specialized scientific consumables to prevent auditing flags during reviews of Horizon Europe proposals.

Proposal teams must submit all budget items in the host institution's local currency, mapping them to the specific electronic submission environment (Funding & Tenders Portal). Every cost item must be justifiable as necessary, reasonable, and allocable to the project.

2. Direct vs. Indirect Cost Categorisation

A primary point of auditing compliance is the strict division between Direct Costs (expenses directly attributable to the execution of the research project) and Indirect Costs (institutional overheads, facility maintenance, and central administrative support).

For **Clinical Medicine & Trials** projects under **Horizon Europe** rules, indirect overheads are simplified via a standard 25% flat rate. This flat-rate overhead is calculated from the total eligible direct costs, making sure to deduct any external subcontracting costs.

For Horizon Europe proposals, the indirect cost rate is structured as: 25% Flat Rate. This rate must be applied correctly to the modified total direct cost base according to your institution's negotiated rate agreement or the flat rate set by the funder.

3. Step-by-Step Budget Justification Protocol

The budget justification (or budget narrative) is a critical component of the application reviewed by both financial auditors and peer reviewers. To draft a compliant narrative:

• Provide granular detail: Do not use lump sums. Break down personnel costs by calendar months or percentage of effort.
• Demonstrate direct linkage: For every cost, explain how it supports a specific task or objective in the research plan for Clinical Medicine & Trials.
• Cite institutional policies: Reference verified institutional rates for fringe benefits, travel mileage, and indirect cost bases to validate your numbers.
• Verify supplier quotes: For major equipment purchases or specialized laboratory assays, upload or reference formal vendor quotes.

Pre-Award Framework, Cost Sharing & Post-Award Governance

When preparing a funding proposal for the Horizon Europe framework programme (Horizon Europe) inside the field of Clinical Medicine & Trials, mastering grant development and proactive pre-award grant management is an essential baseline step to clear administrative filters. Unlike discretionary block grants given directly to departments, these funds are administered as categorical grants restricted to specified scientific deliverables under Horizon Europe rules. When building the grant proposal timeline, the PI and co-principal investigator must ensure there is sufficient margin for institutional review and formal clearance of any cost sharing on grants. Post-award compliance enforces systematic post-award grant management, which includes drafting a formal subaward agreement research with participating research groups. Under active guidelines, project teams must submit formal effort certification research audits, enabling the PI to track personnel hours during collaborative team science research in Clinical Medicine & Trials.

4. Frequently Asked Questions